Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction

Details for Australian Patent Application No. 2003240670 (hide)

Owner NOVARTIS AG

Inventors McMurray, John J. V.; Califf, Robert M.; Pfeffer, Marc A.; MacNab, Malcolm

Agent Davies Collison Cave

Pub. Number AU-A-2003240670

PCT Number PCT/EP03/05198

PCT Pub. Number WO2003/097099

Priority 60/381,548 17.05.02 US

Filing date 16 May 2003

Wipo publication date 2 December 2003

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/135 - having aromatic rings, e.g. methadone

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/381,548 17.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003240670

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240671-Highly concentrated aqueous dispersions containing hydrophilic microfine metal oxide particles and a dispersant

2003240669-Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic